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Background: This study examined the effect of storage temperature on the protein profile of human plasma.
Plasma samples were stored for 13 days at −80°C, −20°C, +4°C and room temperature (20-25°C) prior to proteomic
analysis. The proteomic comparisons were based on the differences of mean intensity values of protein spots
between fresh plasma samples (named “time zero”) and plasma samples stored at different temperatures. To better
understand the thermally induced biochemical changes that may affect plasma proteins during storage we
identified proteins with different expressions with respect to the time zero sample.
Results: Using two-dimensional electrophoresis followed by MALDI-TOF MS and /or LC-MS/MS 20 protein spots
representing 10 proteins were identified with significant differences in abundance when stored at different
temperatures. Our results, in agreement with various authors, indicate that during storage for a short period
(13 days) at four different temperatures plasma proteins were more affected by degradation processes at +4°C
compared to the other temperatures analysed. However, we founded that numerous protein spots (vitamin D
binding protein, alpha-1-antitrypsin, serotransferrin, apoplipoprotein A-I, apolipoprotein E, haptoglobin and
complement factor B) decrease in abundance with increasing temperature up to 4°C, but at room temperature
their intensity mean values are similar to those of time zero and −80°C. We hypothesize that these proteins are
labile at 4°C, but at the same time they are stable at room temperature (20-25°C). Furthermore we have grouped
the proteins based on their different sensitivity to the storage temperature. Spots of serum albumin, fibrinogen
gamma chain and haptoglobin are more resistant to the higher temperatures tested, as they have undergone
changes in abundance only at room temperature; conversely, other spots of serum albumin, fibrinogen beta
chain and serotransferrin are more labile as they have undergone changes in abundance at all temperatures
except at −80°C.
Conclusions: Although there are many studies concerning protein stability of clinical samples during storage
these findings may help to provide a better understanding of the changes of proteins induced by storage
temperature.
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Human serum and plasma are the favored specimens
and they are easily accessible for many analysis in prote-
ome research, especially in the biomarker discovery field
[1]. The human blood proteome has a great biological
and clinical importance and reflects the environment of
all cells, tissues and organs in the human body. Human
serum and plasma contains several different water-
soluble components, among them the plasma/serum
proteins. In principle, any protein can become at least
temporarily a blood plasma protein depending on the
actual state of the body, e.g. especially in the case of a
pathological situation [2]. Moreover, a protein that is
not usually present in blood plasma can accumulate in
it as a characteristic diagnostic marker for a certain disease
[3]. Due to the continuous development of proteomic
techniques mainly centered around mass spectrometric
identification [4], the number of proteins annotated and
identified in plasma/serum in recent years is considerably
increased. However proteomic investigations involving hu-
man serum and plasma are complicated because there are
a wide range of pre-analytical variables that could lead to
alteration of the detected proteome [5]. The more import-
ant variables for sampling procedures of plasma/serum
proteomes are related to the selection of blood collection
tubes and anticoagulants [6-8], variations in clotting time
or time lag before centrifugation [9], hemolysis, centrifu-
gation speed or time, storage temperature [10] and re-
peated freeze/thaw cycles [9,11]. Moreover, in proteomic
research it’s very important the choice of the sample type
[7,12]; the quality of specimens affects the validity of the
analytical data, which makes the integrity of samples an
important issue. In principle, depending on analytical ob-
jectives and/or target peptides or proteins, the use of ei-
ther plasma or serum may impact both method and
results. In regard to peptidomics, Tammen et al. [13]
found that a significant number of peptides was different
not only between serum and plasma specimens but also
among plasma specimens prepared with different antico-
agulants. Plasma and serum protein profiles reported by
various laboratories are often variable, reflecting different
analytical methods and sample preparation processes
[11,13-15]. In this context it is very important to estab-
lish a standard protocol to monitor the stability of
human plasma/serum samples upon storage. In this
work we studied the pre-analytical stability of the
plasma proteomes based on the storage temperature
using proteomic techniques including two dimensional
electrophoresis and MALDI-TOF MS (matrix assisted
laser desorption/ionization time of-flight mass spec-
trometry) and/or LC-MS/MS (liquid chromatography-
tandem mass spectrometry) [16-18]. Plasma samples
were stored for 13 days at −80°C, −20°C, +4°C and room
temperature (20-25°C) prior to proteomic analysis. Theproteomic comparisons were based on the differences of
the mean intensity values of the protein spots between
fresh plasma samples (named “time zero”) and plasma
samples stored at different temperatures. To better
understand the thermally induced biochemical changes
that may affect plasma proteins during storage we iden-
tified proteins with different expressions with respect to
the time zero sample. The subjects examined were
recruited through the “AkeA Project” [19] (approved by
the bioethical committee) that study human longevity in
Sardinia and includes a very great number of plasma
samples of Sardinian people spanning from 20 to 112 -
years. In this project, started in 1997, the researcher’s
group performed good results in the collection proce-
dures, in the study of the biochemical, genetic and
environmental conditions involved in the ageing pro-
cesses. Moreover, within the “AkeA project” proteomic
studies were performed in order to evaluate changes in
proteins associated with human longevity.
Results and discussion
In the present work, the influence of the storage
temperature on the stability of human plasma proteins
was analysed by two-dimensional electrophoresis on
polyacrylamide gels (2D-PAGE) and mass spectrometry.
The proteomic comparisons were based on the differences
of mean intensity values of protein spots between fresh
plasma samples (named “time zero”) and plasma samples
stored at four different temperatures [−80°C, -20°C, +4°C
and room temperature (20-25°C)] for a period of 13 days.
The software used for image analysis (PD QUEST) has
detected about 500 valid spots of which 20 spots were
found to show significant changes (higher than two fold,
p ≤ 0.05) in intensities compared with the time zero sam-
ple. These spots were further identified by MALDI-TOF
MS (Table 1) (see also Additional file 1: Table S1) and/or
LC-MS/MS analysis (Table 2) (see also Additional file 2:
Table S2). Representative 2D gels image is reported in
Figure 1. In general, the 2-D profile appeared well pre-
served after 13 days of storage at −80°C, in fact, in these
samples any statistically significant change with respect to
the time zero sample was observed. As expected, a higher
number of spots showed a significant quantitative vari-
ation in plasma stored at higher temperatures. Table 3
shows the 7 spots that significantly change between
storage at −20°C and the time zero. Between them we
can recognize some of the most abundant proteins in
plasma, like serum albumin (3, 4) [Swiss-Prot: P02768],
alpha-1-antitrypsin (6) [Swiss-Prot: P01009], fibrinogen
beta chain (8) [Swiss-Prot: P02675], serotransferrin (14,
15) [Swiss-Prot: P02787] and apolipoprotein A-I (16)
[Swiss-Prot: P02647] with all of them decreasing in
intensity if compared to time zero except for the
fibrinogen beta chain. Table 4 shows the 16 spots that
Table 1 Plasma protein spots identified by MALDI-TOF MS
Spot Identified protein Acc. no. a Score b QM c % C d Theoretical Mr/pI e Observed Mr/pI f
ALB/AFP/VDB family
1 Vitamin D-binding protein P02774 100 11 43 52964/5.4 55700/5.3
2 Serum albumin P02768 95 12 28 69367/5.92 67600/5.4
3 Serum albumin P02768 142 18 41 69367/5.92 57000/5.4
4 Serum albumin P02768 224 21 43 69367/5.92 56900/5.6
Serpin family
5 Alpha-1-antitrypsin P01009 133 17 34 46737/5.37 56000/5.0
6 Alpha-1-antitrypsin P01009 117 10 32 46737/5.37 56100/5.1
Fibrinogen alpha/beta family
7 Fibrinogen beta chain P02675 41 7 20 55928/8.54 55700/6.3
8 Fibrinogen beta chain P02675 95 10 27 55928/8.54 55300/6.4
9 Fibrinogen gamma chain P02679 177 14 43 51512/5.37 51500/5.7
10 Fibrinogen gamma chain P02679 177 14 45 51512/5.37 51700/5.3
11 Fibrinogen gamma chain P02679 164 14 39 51512/5.37 51200/5.6
12 Fibrinogen gamma chain P02679 177 14 43 51512/5.37 51700/5.5
Transferrin family
13 Serotransferrin P02787 423 40 54 77064/6.81 57200/6.4
14 Serotransferrin P02787 81 10 20 77064/6.81 57300/6.3
15 Serotransferrin P02787 196 20 31 77064/6.81 57400/6.4
Apolipoprotein AI/A4/E family
16 Apolipoprotein A-I P02647 60 7 28 30778/5.56 23000/5.2
17 Apolipoprotein-E P02649 151 17 55 36154/5.65 33500/5.6
Peptidase S1 family
18 Haptoglobin P00738 64 9 19 45205/6.13 45300/5.0
19 Haptoglobin P00738 70 10 25 45205/6.13 42800/5.5
20 Complement factor B P00751 60 5 13 85533/6.67 97900/6.2
a Accession number (database: UniProtKB/Swiss-Prot).
b Score: probability score in MASCOT program (the probability that the observed match between the experimental data and mass values calculated from a
candidate peptide sequence is a random event).
c Queries matched indicates the number of matched peptides in the database search.
d Percent coverage: the minimum coverage of the matched peptide in relation to the full-length sequence.
e Theoretical molecular weight/isoelectric point of full-length protein according to the Swiss-Prot database.
f Molecular weight/isoelectric point of full-length protein calculated upon calibration of electrophoretic gels.
Table 2 Plasma protein spots identified by LC-MS/MS
Spot Identified protein Acc. no. a Score b QM c % C d
1 Vitamin D-binding protein P02774 279 24 44
13 Serotransferrin P02787 441 45 42
17 Apolipoprotein-E P02649 239 15 39
a Accession number (database: UniProtKB/Swiss-Prot).
b Score: probability score in MASCOT program (the probability that the
observed match between the experimental data and mass values calculated
from a candidate peptide sequence is a random event).
c Queries matched indicates the number of matched peptides in the
database search.
d Percent coverage: the minimum coverage of the matched peptide in relation
to the full-length sequence.
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protein spots comprise all of the ones that change with
storage at −20°C and 9 more spots: Vitamin D-binding
protein (1) [Swiss-Prot: P02774], Alpha-1-antitrypsin (5),
Fibrinogen beta chain (7), Fibrinogen gamma chain
(9, 11), Serotransferrin (13), Apolipoprotein-E (17) [Swiss-
Prot: P02649], Haptoglobin (19) [Swiss-Prot: P00738] and
Complement factor B (20) [Swiss-Prot: P00751]. The
majority of these spots decrease in intensity compared to
time zero except for fibrinogen beta chain (7, 8) and
fibrinogen gamma chain (9, 11) that conversely increase.
The Table 5 shows the changes between room temperature
and time zero with changes for 10 spots, three of which
decrease [albumin (2, 3) and serotransferrin (15)] and nine
increase [fibrinogen beta chain (7, 8), fibrinogen gamma
Figure 1 Images from the 2D gels obtained in this work. (A) 2-DE gel image with plasma proteins of control (time zero, fresh plasma
samples); (B-E) 2-DE gel images corresponding to the plasma samples stored at −80°C, −20°C, +4°C and room temperature respectively. The
plasma was separated on 2-DE gels and visualized by Coomassie blue staining. Proteins undergoing a significant variation in abundance (>2-fold
change) are numbered and indicated by arrows. The molecular weights (MW) and pI scales are indicated. Each gel is representative of three
independent replicates.
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the data presented in Figure 2 we observed with interest
that most of the altered protein spots decrease in abun-
dance with increasing temperature up to 4°C, but at room
temperature their intensity mean values are similar to
those of time zero and −80°C. Of 20 spots that were found
to show significant changes in intensities with respect totime zero, six spots identified as vitamin D-binding
protein (1) [Swiss-Prot: P02774], alpha-1-antitrypsin (5),
serotransferrin(13), apolipoprotein E (17) [Swiss-Prot:
P02649], haptoglobin (19) [Swiss-Prot: P00738] and
complement factor B (20) [Swiss-Prot: P00751] showed a
significant abundance decrease only in plasma stored
at +4°C with respect to the time zero sample but not
Table 3 Protein spots undergoing significant changes
(>2-fold) after storage at −20°C with respect to time zero
Spot Protein name Average ratio −20°C/time
zero
Paired t-test
3 Serum albumin 0.20 0.047
4 Serum albumin 0.20 0.022




14 Serotransferrin 0.49 0.007
15 Serotransferrin 0.29 0.016
16 Apolipoprotein A-I 0.20 0.039
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peratures. Serotransferrin and haptoglobin (spots 13 and
19 respectively) showed the highest abundance decrease,
with an average ratio of 0.12 and 0.09 respectively with
respect to time zero (p = 0.016 and 0.038 respectively),
whereas the other spots (5, 17 and 20) showed an abun-
dance decrease at the same conditions (Table 4). Among
these proteins, spots 1, 5 and 20 showed a higher molecu-
lar weight and a lower isoelectric point than their theoret-
ical values. While, spots 3, 17, and 19 showed lower
molecular weights and isoelectric points than their theor-
etical values (Table 1). Moreover, four spots, identified asTable 4 Protein spots undergoing significant changes
(>2-fold) after storage at +4°C with respect to time zero






3 Serum albumin 0.09 0.047
4 Serum albumin 0.33 0.05
5 Alpha-1-antitrypsin 0.36 0.016













13 Serotransferrin 0.12 0.016
14 Serotransferrin 0.37 0.008
15 Serotransferrin 0.46 0.037
16 Apolipoprotein A-I 0.05 0.02
17 Apolipoprotein-E 0.28 0.002
19 Haptoglobin 0.09 0.038
20 Complement
factor B
0.50 0.015serum albumin (2), fibrinogen gamma chain (10 and 12)
and haptoglobin (18) showed a significant abundance
change only in plasma stored at room temperature with
respect to the time zero sample but not showed any sta-
tistically significant change at the other temperatures.
Spots of fibrinogen gamma chain (10 and 12) showed
the highest abundance increase with an average ratio of
16.35 and 8.34 respectively with respect to time zero
(p = 0.014 and 0.02 respectively), whereas the others spots
(2 and 18) showed an average ratio of 0.35 (p = 0.031) and
3.15 (p = 0.047) respectively (Table 5). Various scientists
recommend that plasma samples should be stored in
liquid nitrogen or at −80°C if this is not available [20].
Sen-Yung Hsieh et al. [11] reported that storage at room
temperature (25°C) and at 4°C caused prominent changes
in the serum/plasma proteome only after 8 h and 48 h of
incubation respectively, particularly for proteins of less
than 3000 Da as demonstrated by using magnetic bead-
based MALDI-TOF MS. They have also compared serum
proteomes from the serum samples freshly obtained or
stored at −80°C for 1 and 3 months, respectively and only
minimal changes were found. Similar results were
reported also by Rai et al. [14] and Marshall et al. [21]. In
agreement with mentioned authors, we found that storage
temperatures have important effects on plasma protein
profiles and that storage of plasma at low temperatures
preserves more plasma proteins than storing them at
higher temperatures. In summary the protein spots under-
going significant variations in abundance (>2-fold change;
p ≤ 0.05) after 13 days of storage at different temperatures
with respect to the time zero can be grouped into six main
protein families: ALB/AFP/VDB family, serpin family,
fibrinogen alpha/beta family, transferrin family, apolipo-
protein A-I/A4/E family and peptidase S1 family (Table 1).
All the spots undergoing significant variations in abun-
dance with increasing storage temperature showed modest
changes of their molecular weights and isoelectric points
compared to the native protein. We founded that all pro-
tein spots belonging to the fibrinogen alpha/beta family
and one spot (18) belonging to the peptidase S1 family
undergo a linear increase in abundance with increasing
temperature. The apparent increase in the abundance of a
spot or a shift in its isoelectric point in the 2-D map can
depend on protein modifications occurring as a result of
biochemical processes, such as dephosphorylation, oxida-
tion or loss of charged amino acid side chains. Moreover,
we founded that most of the protein spots belonging to
the other protein families mentioned above, undergo a
decrease in abundance up to 4°C, but when storing
them at room temperature their intensity mean values
are similar to those of the time zero sample. This is the
case of proteins identified as vitamin D binding protein
(1), alpha-1-antitrypsin (4 and 5), serotransferrin (13
and 14), apoplipoprotein A-I (16), apolipoprotein E (17),
Table 5 Protein spots undergoing significant changes
(>2-fold) after storage at RT with respect to time zero
Spot Protein name Average ratio -RT/time
zero
Paired t-test
2 Serum albumin 0.35 0.031



















15 Serotransferrin 0.42 0.037
18 Haptoglobin 3.15 0.047
Pasella et al. Proteome Science 2013, 11:10 Page 6 of 10
http://www.proteomesci.com/content/11/1/10haptoglobin (19) and complement factor B (20). The
abundance decrease and the shift in the isoelectric
points and in the molecular weights of these spots com-
pared to the native protein may be caused by proteolytic
processes, leading to the formation of fragments of the
native protein. We hypothesize that these proteins are
labile at 4°C, but at the same time they are stable at
room temperature (20-25°C). Furthermore we have
grouped the proteins based on their different sensitivity
to the storage temperature; proteins identified as serum
albumin (2), fibrinogen gamma chain (10 and 12) and
haptoglobin (18) are more resistant to higher tempera-
tures, as they have undergone changes in abundance
only to room temperature. Conversely, spot 3 of serum
albumin, spot 8 of fibrinogen beta chain and spot 15 of
serotransferrin are more labile as they have undergone
changes in abundance at all temperatures except at
−80°C. Monitoring changes of the protein spots abun-
dance was useful to get an overview of the importance
of the degradation processes that occur in plasma sam-
ples during the storage period and to identify which
proteins are involved in these changes. Although there
are many studies concerning protein stability of clinical
samples during storage these findings may help to pro-
vide a better understanding of the changes of proteins
induced by storage temperature.
Conclusions
In agreement with various authors, the comparative
proteomic analysis of human plasma samples under
different storage temperatures indicated that storage at
high temperature reduces considerably the stability of
plasma proteomes. However, we observed with interestthat some proteins are more labile at +4°C than at room
temperature. Furthermore we observed modest varia-
tions of the molecular weight and isoelectric point of
these protein spots compared to the native proteins.
Even if more studies are needed, these findings may be
useful in understanding the degradative mechanisms
taking place in the plasma samples in order to eliminate




Protease Inhibitor Cocktail for general use, Angiotensina
II, [Val5]Ang I, [Glu1]-Fibrinopeptide B human, ACTH
[1-17], ACTH [18–39], ACTH [7–38], alpha cyano-4-
hydroxycinammico (CHCA), trifluoroacetic acid (TFA)
and Acetonitrile LC-MS CHROMASOLV were from
Sigma Aldrich.
Human plasma samples
The population was chosen in order to have a low vari-
ability of gender and age. Plasma samples were from 6
subjects including 3 males and 3 females aged between 23
and 32 years. The donors were healthy volunteers and/or
not suffering from diseases such as vascular disease,
stroke, diabetes or cancer. All volunteers were recruited
from the Akea Project (project approved by the local
bioethics) and all of them signed a written consent prior
to blood sampling. Blood samples were collected early
in the morning to reduce the biological variability, by
venipuncture into vacutainer (Greiner bio-one, Austria)
containing K2 EDTA as anticoagulant. Immediately after
the blood collection protease inhibitors (Protease Inhibitor
Cocktail, Sigma P2714) were added in the ratio of 1:100
into the vacutainer; then we proceeded to the separation
of the plasma by centrifugation at 2500 g for 15 minutes
at 4°C. The supernatant containing the plasma was
divided into a defined number of aliquots of 200 μl each.
The blood and plasma sample handling and processing
was carried out in a short time (about 30 min). One ali-
quot of plasma sample was used for protein extraction in
the same day of which blood samples were collected;
plasma sample purified were then used for 2DE and MS
and/or MS/MS analysis; this sample, named “time zero”
was used as a reference sample for all subsequent pro
teomic comparisons. The other aliquots were stored
at −80°C, −20°C, +4°C and room temperature (20 to
25°C) respectively and were analyzed after 13 days. For
each experiment studied (time zero, −80°C, −20°C, 4°C
and room temperature ) we analyzed a pooled sample
comprising equal amounts of each of the samples in the
study. As we have considered three replicates for each
sample we analyzed a total of 15 gels. Proteins were
extracted from plasma samples using Albumin and IgG
Figure 2 (See legend on next page.)
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(See figure on previous page.)
Figure 2 Protein patterns showing significant changes (>2-fold) under different storage temperature with respect to time zero. The
letters A-L represent the protein spots that showed statistically significant (p ≤ 0.05) change from control (time zero, fresh plasma samples):
(A) vitamin D-binding protein; (B) serum albumin; (C) alpha-1-antitrypsin; (D) fibrinogen beta chain; (E) fibrinogen gamma chain;
(F) serotransferrin; (G) apolipoprotein A-I; (H) apolipoprotein-E; (I) haptoglobin; (L) Complement factor B. The data represent the mean intensity
values (±SD) from three replicates at each temperature. The bars with an asterisk indicate significant difference (p ≤ 0.05) with respect to the
group “time zero”.
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Depletion kit, Sigma, P1120) according to the manu-
facturer’s instructions [22-24]. The protein extracts
were resuspended in sample buffer containing Urea
7 M, Thyourea 2 M and CHAPS 4% and quantified by a
modified Lowry assay according to the manufacturer’s
instructions (DC protein assay kit, BioRad).
Two-dimensional gel electrophoresis (2-DE) and
visualization
Total protein extracts were separated by 2D-PAGE gels
[25]. Analytical gels contained 250 μg of total protein
extracts; for preparative gels 1000 μg of protein were
applied. Three experimental replicates were performed
for each sample. The first dimension isoelectric focusing
(IEF) was performed using the Protean IEF Cell system
(Biorad). Immobilized pH gradient strips (IPG strips)
(linear pH 3–10, 17 cm) were rehydrated with rehy-
dration buffer (urea 8 M, thyourea 2 M, 4% CHAPS,
destreak reagent, 10 mM dithiothreitol, 1% carrier
ampholyte 5–8 and 0.05% bromophenol blue) for 20 hours
at 20°C without voltage. IEF was carried out using a
multi-step procedure (2 hr at 250 V, 2 hr at 500 V, 2 hr
at 750 V, 2 hr at 1000 V, 2 hr at 5000 V, 2 hr at 8000 V,
at 8000 V for 50.000 Volthours, for a total of 70.000 V).
Focused IPG strips were equilibrated in two steps
(15 min each) in 1 ml freshly prepared sample buffer
(50 mM Tris–HCl pH 8.8, 6 M urea, 20% (v/v) glycerol and
2% (w/v) SDS, 1% (w/v) bromophenol blue) supplemented
with 2% dithiothreitol and 2.5% iodoacetamide respect-
ively. Equilibrated IPG strips were transferred into 5-15%
gradient acrylamide gels and embedded with 0.5% w/v
melted agarose. Separation in the second dimension
was performed for 15 min at 25 mA and then for ~4 hr
at 50 mA in Tris-glycine-SDS running buffer, using the
Protean Multicell (BioRad) apparatus [26].
Image analysis
The gels were stained overnight in Coomassie Brilliant
Blue R-250 (CBB R-250) solution (0.05% (w/v) CBB R-
250, 50% (v/v) methanol, 10% (v/v) acetic acid). Gels were
scanned using a GS-800 densitometer (BioRad) and
analyzed with the PDQuest 2D image analysis software
(advanced version, BioRad) [27,28]. The image analysis
allowed to compare the protein spot mean intensity values
(OD, optical density) from the different experiments. Thevolume of all matched spots were normalized with the
“Local Regression Model” method (LOESS); this method
uses the raw quantity of each spot in a member gel, multi-
plied by a factor based on the local regression method of
the matched spots. In order to exclude artifacts and false
positive we confirmed manually both matching and data
quality of all the spots: only those spots that were detect-
able in all gels of a sample set were considered for
evaluation.
In-gel digestion of proteins
Spots of interest were manually excised from the prepara-
tive gels, chopped up into little pieces and digested with
trypsin [29]. Each small gel piece with protein was trans-
ferred into tubes, washed 3 times for 15 minutes with
50 mM NH4HCO3 pH 8 and then with100% acetonitrile
(ACN) for another 15 minutes. The gel pieces were
reduced with 10 mM DTT in 50 mM NH4HCO3 for
45 min at 56°C and alkylated with 55 mM iodoacetamide
in 50 mM NH4HCO3 for 30 min at room temperature in
the dark. They were washed 5 times for 15 minutes with
50 mM NH4HCO3 pH 8 and then with 100% ACN for an-
other 15 minutes. After total evaporation of the ACN the
gel pieces were hydrolyzed with 10 μl of trypsin (10 ng/ul)
in 50 mM NH4HCO3 pH 8. After 2 hours of incubation
on ice the supernatant was removed and the gel pieces
were resuspended in 50 mM NH4HCO3 pH 8; the
samples were incubated overnight at 37°C. After diges-
tion, the protein peptides were acidified with 20% TFA
(1 μl TFA 20%/10 μl of protein peptides), evaporated in a
vacuum centrifuge and resuspended in 5 μl of 2% TFA.
Protein identification by mass spectrometry
Protein spots with a statistically significant variation
(p ≤ 0.05), showing an over two-fold difference in
volume, were selected as differentially expressed and
analyzed by MS and MS/MS analysis. MS analysis was
performed on a MALDI-TOF mass spectrometer micro
MX™(Waters) [30,31]. One μl of tryptic peptide solu-
tion of each digested spot was mixed with an equal
amount of the matrix α-cyano-4-hydroxycinnamic acid
(CHCA), prepared in 0,2% TFAaq and in 70% CAN, ap-
plied on a MALDI plate and dried at room temperature.
All spectra were acquired in reflectron mode, positive
ion, mass range from 800–4000 Da. Ionization was
performed by irradiation with a nitrogen laser (wave
Pasella et al. Proteome Science 2013, 11:10 Page 9 of 10
http://www.proteomesci.com/content/11/1/10length, 337 nm) operating at 20 Hz. For matrix suppres-
sion, we used an high gating factor with signal suppression
of up to 800 Da. The spectra were calibrated externally
resulting in mass accuracy better than 100 ppm [32],
using the following mixture of peptides: Angiotensina II
(m/z 1046,5423 Da), [Val5]Ang I (m/z 1282,662 Da),
[Glu1]-Fibrinopeptide B human (m/z1570,67 Da),
ACTH [1-17] (m/z 2093,09 Da), ACTH [18–39] (m/z
2465,2 Da), ACTH [7–38] (m/z 3657,93 Da). All spectra
were analyzed using the Mass Linx v 4.1 software (Waters).
Protein identification was performed by peptide mass
fingerprinting (PMF) using MASCOT software searching
at http://www.matrixscience.com. Search parameters were
restricted to Homo sapiens taxonomy using the SwissProt
database. Enzyme selection was trypsin, with up to one
missed cleavage permitted. Carbamidomethylation of cys-
teines was selected as a fixed modification; Gln- > pyro
-Glu (N-term Q),Oxidation (M) as variable modifications.
Protein mass was unrestricted, and peptide mass tolerance
typically set at ±150 ppm. Mass values were entered as
monoisotopic MH+. LC-MS/MS analysis was performed
on an XCT Ultra 6340 ion trap equipped with a 1200
HPLC system and a chip cube (Agilent Technologies, Palo
Alto, CA, USA). After loading, samples were concentrated
and desalted at 4 mL/min on a 40-nL enrichment column
(75 mm_43 mm, Agilent Technologies), with 0.2% formic
acid. Peptides were then fractionated on a C18 reverse-
phase capillary column at a flow rate of 300 nL/min, with
a linear gradient of eluent B (0.2% formic acid in 95%
ACN) in A (0.2% formic acid in 2% ACN) from 3–60% in
20 min. ESI parameters were as follows: capillary voltage
1730 V; dry gas (N2), 5.00 L/min; dry temperature, 3251C;
trap drive, 100; skimmer 30 V; lens 1, _5.00 V; octopole
RF amplitude, 200 Vpp; capillary exit, 90 V. The ion-trap
mass spectrometer was operated in a positive-ion mode.
Trap ICC smart target was 30 0000 units and maximal
accumulation time was 100 ms. MS/MS was operated at
a fragmentation amplitude of 1.3 V, and threshold ABS
was 6000 units. Scan speed was 8100 UMA/s in MS and
26 000 UMA/s in MS/MS scans. Peptide analysis was
performed scanning from m/z 250 to m/z 2200 in
AutoMS (n) precursor selection mode of the three most
intense ions (fragmentation mass range from 100 to
2200 m/z). Dynamic exclusion was used to acquire a
more complete survey of the peptides by automatic
recognition and temporary exclusion (0.15 min) of ions
from which definitive mass spectral data had previously
acquired. Data analysis software, provided by the manu-
facturers, was used to analyze MS/MS spectra and to
generate a peak list that was introduced in the in-house
MASCOT MS/MS ion search software (Version 2.3,
Matrix Science, Boston, MA, USA) for protein identifi-
cation in the NCBI database using the Homo sapiens
taxonomy. Search parameters were as follows: peptidetolerance 300 ppm, MS/MS tolerance 0.6 Da, enzyme tryp-
sin, allowing one missed cleavage. Carbamidomethylation
of cysteines was selected as a fixed modification;
Gln- > pyro-Glu (N-term Q),Oxidation (M), Phospho
(ST), Phospho (Y) as variable modifications.
Statistical data analysis
The average intensities of resolved spots were compared
using quantitative (2.0-fold increase or decrease ratios)
functions within the PDQuest software. The quantity
tables were exported and all the statistical analysis were
performed using the paired t-test implemented in the
Sigma Stat 3.1 software. P-values ≤0.05 were considered
significant. Among all statistically significant spots, only
those that showed changes of the mean intensity values
at least by a factor 2 with respect to the group “time
zero” were selected, in order to exclude the impact of
experimental variability and consider more reliable data.
Additional files
Additional file 1: Table S1. The matched peptides sequences of each
protein spots identified through MALDI-TOF MS.
Additional file 2: Table S2. The matched peptides sequences of each
protein spots identified through LC- MS/MS.
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